Nisa Investment Advisors, LLC Rapt Therapeutics, Inc. Transaction History

Nisa Investment Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$2.89 - $9.38 $54 - $178	19 Added 95.0%	39 $0
Q1 2024 May 01, 2024	BUY	$6.87 - $26.45 $75 - $290	11 Added 122.22%	20 $0
Q4 2023 Jan 25, 2024	SELL	$11.28 - $25.46 $169 - $381	-15 Reduced 62.5%	9 $0
Q3 2023 Nov 02, 2023	BUY	$16.34 - $24.66 $98 - $147	6 Added 33.33%	24 $0
Q4 2022 Feb 02, 2023	SELL	$16.28 - $24.6 $81 - $123	-5 Reduced 21.74%	18 $0
Q3 2022 Nov 07, 2022	BUY	$17.96 - $30.46 $413 - $700	23 New	23 $1,000
Q4 2020 Jan 25, 2021	SELL	$15.89 - $40.87 $5,243 - $13,487	-330 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$14.16 - $32.85 $2,690 - $6,241	190 Added 135.71%	330 $10,000
Q1 2020 Apr 17, 2020	BUY	$11.86 - $48.86 $1,660 - $6,840	140 New	140 $3,000

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.